The broken lines in the figures are included for the purpose of illustrating portions of the tunneling tool that form no part of the claimed design.
The broken lines in the figures are included for the purpose of illustrating portions of the tunneling tool that form no part of the claimed design.
Number | Name | Date | Kind |
---|---|---|---|
D377524 | Lipp | Jan 1997 | S |
D460554 | Park | Jul 2002 | S |
D461246 | Park | Aug 2002 | S |
D492776 | Nilsson | Jul 2004 | S |
D492995 | Rue et al. | Jul 2004 | S |
D549825 | O'Neill | Aug 2007 | S |
D627882 | Slowey et al. | Nov 2010 | S |
7850639 | Rue et al. | Dec 2010 | B2 |
D697208 | Ehrlich | Jan 2014 | S |
20130108680 | Schwarz | May 2013 | A1 |
20130115264 | Schwarz et al. | May 2013 | A1 |
20130144250 | Schwarz et al. | Jun 2013 | A1 |
20130259934 | Schwarz | Oct 2013 | A1 |
Entry |
---|
“Highlights of Supprelin Prescription Information”, Endo Pharmaceuticals (2012) PK000033 Rev. 07, 20 pgs. |
“Highlights of Vantas Prescription Information”, Endo Pharmaceuticals (2012) PK000003 Rev. May 10, 2012, 22 pgs. |